Gordon Law

机构：AstraZeneca (United States)

发表论文 14 篇 · 总被引 9082 次 · h-index 9

代表论文

• Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (2017 · New England Journal of Medicine · 被引 7851)
• Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus (2015 · The Journal of Clinical Endocrinology & Metabolism · 被引 454)
• Ziprasidone Treatment of Children and Adolescents With Tourette's Syndrome: A Pilot Study (2000 · Journal of the American Academy of Child & Adolescent Psychiatry · 被引 341)
• Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus (2013 · Obesity · 被引 168)
• Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials (2017 · Diabetes Obesity and Metabolism · 被引 103)
• Cardiac Abnormalities in Diabetic Patients With Neuropathy (2004 · Diabetes Care · 被引 84)